Alkermes plc - Ordinary Shares (ALKS) News
Filter ALKS News Items
ALKS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ALKS News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest ALKS News From Around the Web
Below are the latest news stories about ALKERMES PLC that investors may wish to consider to help them evaluate ALKS as an investment opportunity.
The Cream Of The Crop: 5 Biotechs That Outrank Most StocksThe top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders. |
Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceAlkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation will take place on Wednesday, Jan. 15, 2025 at 11:15 a.m. PST (2:15 p.m. EST/7:15 p.m. GMT), followed by a question and answer session. The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days. |
Declining Stock and Solid Fundamentals: Is The Market Wrong About Alkermes plc (NASDAQ:ALKS)?With its stock down 2.4% over the past week, it is easy to disregard Alkermes (NASDAQ:ALKS). However, stock prices are... |
Qiagen (QGEN) Down 1.6% Since Last Earnings Report: Can It Rebound?Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Ultragenyx (RARE) Down 6.8% Since Last Earnings Report: Can It Rebound?Ultragenyx (RARE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Illumina (ILMN) Down 9.3% Since Last Earnings Report: Can It Rebound?Illumina (ILMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Glaxo (GSK) Down 6.6% Since Last Earnings Report: Can It Rebound?Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Why Is Incyte (INCY) Up 2.1% Since Last Earnings Report?Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Axsome Therapeutics eyes approval after Phase III narcolepsy winThe company’s Phase III trial of AXS-12 showed results over placebo as the company looks towards filing a new drug application for its narcolepsy therapy. |
Alkermes to Participate in Upcoming Investor ConferencesAlkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences. |